RSC Advances
Page 6 of 7
DOI: 10.1039/C5RA06373F
°C for 5 h to afford the 1%, 2.5% & 5% w/w of the Mn/ZrO2 catalysts.
General Procedure for the synthesis of pyrano[2,3-d]-pyrimidines:
A solution containing dimethylbarbituric acid (1 mmol), substituted
aldehyde (1 mmol), malononitrile (1.1 mmol) and Mn/ZrO2 (30 mg) in
mixture of EtOH:H2O (1:1 v/v, 10 mL) was continuously stirred for 1.0 h
at RT using a magnetic stirrer (Scheme 1). The progress and completion
DMSOꢀd6) δ 7.22 (s, 2H, NH2); IR (KBr, cmꢀ1): 3317, 2937, 2188, 1681,
35 1645, 1474; HRMS of [C18H18N4O5 + Na] (m/z): 393.1166; Calcd.:
393.1175..
7-Amino-5-(2,5-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4c): 1H NMR
(400 MHz, DMSOꢀd6) δ = 3.07 (s, 3H, NCH3), 3.38 (s, 3H, NCH3), 3.65
5
of the reaction was monitored by TLC. The reaction mixture was then 40 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 4.58 (s, 1H, CH), 6.64 (d, J = 3.02
filtered, and the filtrate was subsequently evaporated under reduced
pressure to obtain the crude product which was recrystallized with ethanol
Hz, 1H, ArH), 6.74 (dd, J = 8.9, 3 Hz, 1H, ArH), 6.89 (d, J = 8.9 Hz, 1H,
ArH), 7.15 (s, 2H, NH2); 13C NMR (100 MHz, DMSOꢀd6): δ 27.59, 29.00,
31.32, 55.22, 56.34, 57.63, 88.05, 111.51, 112.76, 115.37, 119.02, 130.99,
150.00, 150.23, 151.52, 153.15, 158.15, 160.34; 15N NMR (40.55 MHz,
45 DMSOꢀd6) δ 7.15 (s, 2H, NH2); IR (KBr, cmꢀ1): 3302, 3175, 2934, 2194,
1715, 1683, 1634, 1599, 1487; HRMS of [C18H18N4O5 ─ H] (m/z):
369.0389; Calcd.: 371.0395.
10 to afford pure product (4aꢀk). The recovered catalyst was subjected to
washing with ethanol, dried and reꢀused for up to six cycles.
R
O
7-Amino-5-(2-bromophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-
1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4d): 1H NMR (400 MHz,
50 DMSOꢀd6) δ = 3.05 (s, 3H, NCH3), 3.36 (s, 3H, NCH3), 4.86 (s, 1H, CH),
7.11ꢀ7.15 (m, 1H, ArH), 7.28 (d, J = 4.2 Hz, 2H, ArH), 7.33 (s, 2H, NH2),
7.53 (d, J = 8.00 Hz, 1H, ArH); 13C NMR (100 MHz, DMSOꢀd6): δ 27.58,
29.12, 35.80, 57.36, 88.23, 118.42, 122.77, 128.07, 128.64, 130.25,
132.45, 149.97, 151.47, 157.64, 160.28; 15N NMR (40.55 MHz, DMSOꢀ
55 d6) δ 7.33 (s, 2H, NH2); IR (KBr, cmꢀ1): 3310, 2930, 2913, 1684, 1637,
1470; HRMS of [C16H13BrN4O3 ─ H] (m/z): 387.0103; Calcd.: 387.0093..
7-Amino-5-(4-bromophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-
1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4e): 1H NMR (400 MHz,
DMSOꢀd6) δ = 3.07 (s, 3H, NCH3), 3.34 (s, 3H, NCH3), 4.32 (s, 1H, CH),
60 7.21 (d, J = 8.00 Hz, 2H, ArH), 7.35 (s, 2H, NH2), 7.47 (d, J = 8.00 Hz,
2H, ArH); 13C NMR (100 MHz, DMSOꢀd6): δ 27.62, 29.09, 36.04, 58.03,
88.22, 118.85, 119.80, 129.67, 131.07, 143.54, 149.95, 151.15, 157.57,
160.43; 15N NMR (40.55 MHz, DMSOꢀd6) δ 7.35 (s, 2H, NH2); IR (KBr,
cmꢀ1): 3426, 3299, 2930, 2189, 1683, 1633, 1487.
CHO
O
N
CN
Mn/ZrO2
N
CN
CN
N
r.t., EtOH:H2O
O
N
O
NH2
O
O
R
4(a-k)
1(a-k)
3
2
Scheme 1: Synthesis of pyrano[2,3-d]-pyrimidine derivatives
H
CN
O
CN
O
H
N
H
HO
NC
N
N
C
CN
O
NC
NC
N
O
Catalyst
Catalyst
Knoevenagel
Condensation
Dehydration
R
R
O
N
R
R
N
O
O
R
R
65 7-Amino-5-(2-chlorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-
1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4f): 1H NMR (400 MHz,
DMSOꢀd6) δ = 3.06 (s, 3H, NCH3), 3.36 (s, 3H, NCH3), 4.86 (s, 1H, CH),
7.23ꢀ7.36 (m, 6H, ArH, NH2); 13C NMR (100 MHz, DMSOꢀd6): δ 27.59,
29.11, 33.52, 57.18, 87.97, 118.52, 127.46, 128.37, 129.24, 132.17,
70 141.08, 149.97, 151.50, 157.76, 160.28; 15N NMR (40.55 MHz, DMSOꢀ
d6) δ 7.30 (s, 2H, NH2); IR (KBr, cmꢀ1): 3382, 3310, 3193, 2959, 2193,
1703, 1684, 1638, 1474; HRMS of [C16H13ClN4O3 ─ H] (m/z): 343.0992;
O
N
O
H
CN
CN
N
Cyclization
N
C
NH
O
O
N
O
NH2
O
Mechanism 1. Plausible reaction mechanism for the formation of
pyrano[2,3-d]-pyrimidine derivatives
15
Calcd.: 343.1008.
7-Amino-5-(3-nitrophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-
75 1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4g): 1H NMR (400 MHz,
DMSOꢀd6) δ = 3.01 (s, 3H, NCH3), 3.34 (s, 3H, NCH3), 5.12 (s, 1H, CH),
7.43 (d, J = 8.00 Hz, 1H, ArH), 7.48 (s, 2H, NH2), 7.51 (s, 1H, ArH), 7.64
(t, J = 8.00, 1H, ArH), 7.83 (d, J = 8.00 Hz, 1H, ArH); 13C NMR (100
MHz, DMSOꢀd6): δ 27.57, 29.11, 30.77, 56.62, 88.33, 118.40, 123.63,
80 128.02, 130.73, 133.42, 138.38, 149.05, 149.87, 151.82, 158.31, 160.50;
15N NMR (40.55 MHz, DMSOꢀd6) δ 7.48 (s, 2H, NH2); IR (KBr, cmꢀ1):
3373, 3306, 3184, 2957, 2196, 1706, 1683, 1632, 1522, 1490; HRMS of
[C16H13N5O5 ─ H] (m/z): 354.0844; Calcd.: 354.0838.
7-Amino-5-(3-hydroxyphenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-
85 tetrahydro-1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4h): 1H NMR
(400 MHz, DMSOꢀd6) δ = 3.09 (s, 3H, NCH3), 3.35 (s, 3H, NCH3), 4.21
(s, 1H, CH), 6.58ꢀ6.66 (m, 3H, ArH), 7.06 (t, J = 8.00 Hz, 1H, ArH), 7.29
(s, 2H, NH2), 8.42 (s, 1H, OH); 13C NMR (100 MHz, DMSOꢀd6): δ 27.65,
29.05, 36.35, 58.62, 88.98, 113.76, 114.15, 117.92, 119.05, 129.19,
90 145.48, 149.94, 150.96, 157.22, 160.43, 165.86; 15N NMR (40.55 MHz,
DMSOꢀd6) δ 7.29 (s, 2H, NH2); IR (KBr, cmꢀ1): 3370, 3303, 3199, 2965,
2197, 1783, 1636, 1598, 1484; HRMS of [C16H14N4O4 ─ H] (m/z):
325.0894; Calcd.: 325.0900.
7-Amino-5-(4-methoxyphenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4a): 1H NMR
(400 MHz, DMSOꢀd6) δ = 3.07 (s, 3H, NCH3), 3.36 (s, 3H, NCH3), 3.72
(s, 3H, OCH3), 4.31 (s, 1H, CH), 6.83 (d, J = 8.2 Hz, 2H, ArH), 7.14 (d, J
20 = 8.04 Hz, 2H, ArH), 7.29 (s, 2H, NH2); 13C NMR (100 MHz, DMSOꢀd6):
δ 27.64, 29.74, 35.81, 55.02, 58.55, 89.09, 113.64, 119.17, 128.18,
136.81, 149.95, 150.87, 157.88, 158.38, 160.45; 15N NMR (40.55 MHz,
DMSOꢀd6) δ 7.29 (s, 2H, NH2); IR (KBr, cmꢀ1): 3368, 3307, 3181, 2965,
2188, 1682, 1680, 1605, 1508; HRMS of [C17H16N4O4 ─ H] (m/z):
25 339.2011; Calcd.: 339.2021.
7-Amino-5-(2,3-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]-pyrimidine-6-carbonitrile (4b): 1H NMR
(400 MHz, DMSOꢀd6) δ = 3.06 (s, 3H, NCH3), 3.36 (s, 3H, NCH3), 3.75
(s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.61 (s, 1H, CH), 6.71 (d, J = 7.04
30 Hz, 1H, ArH), 6.87 (d, J = 8.00, 1H, ArH), 6.94 (t, J = 7.96, 1H, ArH),
7.22 (s, 2H, NH2); 13C NMR (100 MHz, DMSOꢀd6): δ 27.59, 29.07,
31.06, 55.49, 58.15, 59.90, 83.77, 111.29, 119.07, 120.70, 123.60, 136.99,
146.32, 149.94, 151.28, 152.24, 157.85, 160.37; 15N NMR (40.55 MHz,
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 5